RxDoctor Payments Data

Michael Knox, MD

Urology · Paducah, KYNPI 1518160910

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,553 of the $3,952 with a category attached, or 89.9%. It is spread thinly across 35 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.

$3,952in general payments, 2019–2025

Across 188 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$612
  • Boston Scientific$563
  • Astellas Pharma US Inc$441
  • Intuitive Surgical$405
  • Procept Biorobotics Corporation$318
  • Pfizer$168
  • plus $1K from 29 others

What the payments were for

  • Travel & lodging$1985%
  • Food & beverage$3,55390%
  • Education$2025%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,952 in reported general payments places this provider in the 60th percentile of 139 urology providers in Kentucky.

See all urology providers in Kentucky

Medicare billing

Part B allowed, 2024
$208,566
Medicare patients
447
Services billed
3,467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl269$3,902
Finasteride120$1,412
Testosterone Cypionate12$469
Cephalexin130$294
NitrofurantoinNitrofurantoin Macrocrystal11$264
Alfuzosin Hcl ErAlfuzosin Hcl22$238
Dutasteride14$228
Oxybutynin Chloride ErOxybutynin Chloride53$168
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$133
Ketorolac Tromethamine20$130
Oxycodone Hcl40$58
Sildenafil Citrate11$56
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$56

Paid to pharmacies, not to this prescriber.

Other urology in Paducah

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →